Immunosuppression

LONG BEACH, Calif. — Megalocytic interstitial nephritis may trigger issues with coexisting renal transplant rejection, and providers should focus on immunosuppressive regimen and infection control, according to presented data.

New guidelines for vaccinating adults with solid or hematologic cancers detailed the importance of vaccination optimization, multidisciplinary coordination and vaccination of household members.

Researchers found a complement inhibitor can help reduce rejection.

A biotherapeutics company has raised $120 million to advance its pipeline of cell therapies, including a lead investigational regenerative neural cell therapy candidate to treat drug-resistant mesial temporal lobe epilepsy.

The first patient has been dosed in Artax Biopharma’s phase 2a trial evaluating the safety and biomarker responses of AX-158 in a first proof-of-mechanism trial in psoriasis, the company announced in a press release.

Health officials in Alaska have reported the first-ever death from Alaskapox, and although the disease may be wider spread than previously believed, experts say there is no evidence of risk outside of Alaska.

Kidney Disease: Improving Global Outcomes has released a series of recommendations for the transplant team on how to manage patients with a failing kidney allograft.

LAS VEGAS — Early treatment with tumor necrosis antagonist was linked to 79% reduced odds of patients with pediatric Crohn’s disease developing perianal fistulizing complications, noted a presenter at the Crohn’s & Colitis Congress.

Black patients experience higher acral melanoma rates, as well as melanoma-associated mortality rates, compared with white patients, according to a study.

More than 1 year after the world’s first partial heart transplant in a newborn boy, pediatric transplant cardiologists at Duke Health report that the donor valve tissue is growing with the child.